Flavonoids of the epigeal part ofRhodiola rosea. I

Куркин, В. А.; Zapesochnaya, G. G.; Shchavlinskii, A. N.

doi:10.1007/bf00580087

Cited by 14 publications

(18 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compounds 162‐201 are kaempferol‐type flavonoles. Among them, Compounds 162 , 163 , 164 , 165 ‐ 167 , 168 , 169 , 171‐172 , 173 , 174 , 176 , 182‐183 , 184 , 186 , 188 , 189 , 194 , 195 , 197 , 198 , 199 , and 201 have been found in R. crenulata ; Compounds 163 , 164 , 170 , 171 , 173 , 174 , 177 , 178 , 179 , 181 , 187 , 189 , 190‐191 , 193 , 195 , and 196 have been found in R. rosea ; Compounds 163 , 168 , 171‐172 , 173 , 174 , 179 , 180 , 185‐186 , 189 , 192 , 194 , 198 , and 200 are isolated from R. sachalinensis ; Compounds 163 and 174 are from R. sacra ; Compounds 163 and 189 are isolated from R. quadrifida ; Compounds 163 , 166 , 167 , 173 , 174 , 175 , 188 , and 190 are found in R. dumulosa ...…”

Section: Chemistry and Quality Controlmentioning

confidence: 99%

“…These compounds could be used as potential markers to distinguish R. crenulata and R. rosea with other species. Besides, rhodioflavonoside (Compound 212) is a glycoside coshared between R. rosea and R. quadrifida, 4,71,72,91 while rhodiolgidin (Compound 214) is coexisted in R. crenulata and R. rosea 53,54,114,135. There are three other flavonoles found in R. crenulata, namely crenulatin A (Compound 215), crenulatin B (Compound 216),99 and rhodiolin (Compound 217),56,63,66,87,104,121,126,134 respectively.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study

Tao

Cao

et al. 2019

Medicinal Research Reviews

106

View full text Add to dashboard Cite

Rhodiola species, belonging to the family Crassulaceae, have long been used as an adaptogen, tonic, antidepressant, and antistress medicine or functional food in Asia and Europe. Due to the valuable application, the growing demand of Rhodiola species has led to a rapid decrease in resource content. This review aims to summarize the integrated research progress of seven mainstream Rhodiola species. We first outline both traditional and current use of Rhodiola for the treatment of various diseases. A detailed summary and comparison of chemical, pharmacological, toxicological, and clinical studies of various Rhodiola species highlight recent scientific advances and gaps, which gives insights into the understanding of Rhodiola application and would be helpful to improve the situation of biological resources and diversities of Rhodiola plants.

show abstract

Section: Chemistry and Quality Controlmentioning

confidence: 99%

mentioning

confidence: 99%

Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study

Tao

Cao

et al. 2019

Medicinal Research Reviews

106

View full text Add to dashboard Cite

show abstract

“…Most of its pharmaceutically active secondary metabolites (table 1) are mainly stored in the rhizomes and roots. A large collection of flavonoid compounds has been isolated from the rhizome (rhodionin, rhodiosin, rhodiolin, 8-methylherbacetin, acetylrhodalgin, kaempferol 7-O-α-L-rhamnopyranoside and methyl gallate) and the areal parts of the plant (rhodionin, rhodionidin, rhodiolgin, rhodiolgidin, rhodalin, rhodalidin and caffeic acid) (Kurkin et al 1985).…”

Section: Phytochemical Composition Of Rhodiola Roseamentioning

confidence: 99%

“…Zapesochnaya et al 1983, Kurkin et al 1984, Brown et al 2002, Petsalo et al 2006, Avula et al 2009, Jeong et al 2009 Triterpenes Daucosterol, β-Sitosterol Kurkin et al 1985 Phenolic acids Caffeic acid, Cholorgenic acid, Gallic acid esters , Brown et al 2002 Cyanogenic …”

Section: Conflict Of Interestsmentioning

confidence: 99%

Rhodiola rosea L.: from golden root to green cell factories

et al. 2016

View full text Add to dashboard Cite

“…An analysis of the above-ground part ofRh. rosea led to the isolation of seven compounds [50,53]. On the whole, 25 substances were isolated for the first time, including 13 new compounds whose structures were studied by modern spectroscopic methods and chemical techniques.…”

Section: Rhodiola Rosea: Problems and Prospects Of Creating Preparatimentioning

confidence: 99%

Traditional and biotechnological aspects of obtaining medicinal preparations fromRhodiola Rosea L. (A review)

1999

Self Cite

View full text Add to dashboard Cite

By now, there are about 300 medicinal plants successfully used in medical practice. Moreover, recent years showed a steady tendency for extending this class.Obtaining phytopreparations always involves extraction of the biologically active substances, followed by their separation and purification using various technological methods. One of the main negative factors, introducing instability in the manufacture of phytopreparations, is an irregular character of the supply of raw materials for their production. The reasons include, in particular, a sharp decrease in the natural stock of both wild-growing and cultivated medicinal plants.In connection with this, both the search for new medicinal plants and work on creation of a reliable stock of pharmacopoeial plants are of considerable practical value. Besides the traditional work on large-scale cultivation of medicinal plants, a highly promising direction is the biotechnological production of raw plant materials and related preparations.Biotechnology, which means carrying out technological processes with the aid of biological systems, has been rapidly developing in the past years and is recognized as a priority direction in the future scientific progress [ 1 -8].An important field of biotechnology is the growth of plant cells (or medicinal plant tissue cultures), in which the main difficulties are related to development of the necessary commercial equipment. This field is most extensively developed in Japan, where large-scale cultivation of plant cells was successfully realized many years ago (a 20-m 3 biomass reported in 1976) [1].From the standpoint of the commercial growth of cultures, the most efficient technology is that based on bulk cultivation (suspension cell culture). This method reduces the process time and minimizes manual operations as compared

show abstract

Flavonoids of the epigeal part ofRhodiola rosea. I

Cited by 14 publications

References 0 publications

Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study

Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study

Rhodiola rosea L.: from golden root to green cell factories

Traditional and biotechnological aspects of obtaining medicinal preparations fromRhodiola Rosea L. (A review)

Contact Info

Product

Resources

About